CN113421639B - Clinical path forming system, method, corresponding equipment and storage medium - Google Patents
Clinical path forming system, method, corresponding equipment and storage medium Download PDFInfo
- Publication number
- CN113421639B CN113421639B CN202110459519.6A CN202110459519A CN113421639B CN 113421639 B CN113421639 B CN 113421639B CN 202110459519 A CN202110459519 A CN 202110459519A CN 113421639 B CN113421639 B CN 113421639B
- Authority
- CN
- China
- Prior art keywords
- disease
- clinical path
- hospital
- specific
- clinical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 30
- 201000010099 disease Diseases 0.000 claims abstract description 217
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 217
- 230000037361 pathway Effects 0.000 claims abstract description 26
- 230000004044 response Effects 0.000 claims abstract description 14
- 238000006467 substitution reaction Methods 0.000 claims abstract description 7
- 238000011282 treatment Methods 0.000 claims description 41
- 238000003759 clinical diagnosis Methods 0.000 claims description 12
- 238000004364 calculation method Methods 0.000 claims description 11
- 238000004590 computer program Methods 0.000 claims description 9
- 230000006870 function Effects 0.000 claims description 7
- 238000012790 confirmation Methods 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 238000011161 development Methods 0.000 abstract description 4
- 238000011272 standard treatment Methods 0.000 abstract description 2
- 238000003745 diagnosis Methods 0.000 description 29
- 239000003814 drug Substances 0.000 description 13
- 229940079593 drug Drugs 0.000 description 10
- 206010002091 Anaesthesia Diseases 0.000 description 9
- 230000037005 anaesthesia Effects 0.000 description 9
- 230000006399 behavior Effects 0.000 description 7
- 238000001356 surgical procedure Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000002372 labelling Methods 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 229940069428 antacid Drugs 0.000 description 1
- 239000003159 antacid agent Substances 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000000968 medical method and process Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/20—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the management or administration of healthcare resources or facilities, e.g. managing hospital staff or surgery rooms
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Primary Health Care (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Data Mining & Analysis (AREA)
- Pathology (AREA)
- Databases & Information Systems (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The application discloses a clinical path forming system, a method, corresponding equipment and a storage medium, wherein the system comprises the following modules: determining whether there is a disease specific clinical pathway for a disease species; in response to determining a disease-specific clinical path having the disease species, calculating a utilization rate of each disease-specific clinical path tag from pre-constructed disease-specific clinical path tags; generating a first specific disease recommendation removal and/or inclusion and/or substitution label according to a first predetermined specific disease criterion according to the calculated use rate of each specific disease clinical path label; modifying the dedicated disease clinical path according to the first dedicated disease recommendation removal and/or inclusion and/or replacement tags and taking the modified dedicated disease clinical path as an intra-hospital clinical path. The application can automatically form or update clinical paths meeting the actual and development needs, and realizes standard treatment and accurate cost control.
Description
Technical Field
The present application relates to the field of electronic digital data processing, and more particularly to a clinical path forming system, method, and corresponding apparatus and storage medium.
Background
Clinical pathway (Clinical pathway) is a set of standardized treatment patterns and procedures established for a disease/disease type. The medical behaviors are controlled through the clinical path, so that the effects of standardizing the clinical diagnosis and treatment behaviors, guaranteeing the medical quality and safety and reducing the cost can be achieved. The national health and security commission has issued more than 1000 clinical routes of diseases for all levels of hospitals to reference for medical process guidance, medical quality control and management, and has also included the relevant content of clinical route management into performance assessment management, and clinical route relevant indexes such as the diameter entering rate of the clinical routes, average hospitalization days of single disease types, average cost of single disease types and the like also influence the performance score of the hospitals.
Based on the published clinical paths of the state, a plurality of hospitals are improved on the basis of the published clinical paths, so that own clinical paths are formed for in-hospital management, but diagnosis and treatment projects in the clinical paths are mostly obtained based on expert consensus discussion or guidelines, data support is lacking, and meanwhile, along with the continuous development of medical technology and the continuous updating and refinement of disease diagnosis and treatment schemes, the phenomenon that a large number of out-of-clinical-path projects are required to be applied to patients frequently occurs in the actual application of the current clinical paths, and the phenomenon that the currently used clinical paths cannot adapt to the development and change of the disease diagnosis and treatment is required to be continuously optimized and updated to improve the diameter entering rate and the management and control effect is also described.
Furthermore, the establishment of clinical routes for countries and hospitals is also aimed at optimizing medical and care protocols by disease-specific design. The diagnosis and treatment operation which is carried out conventionally is required in the normal diagnosis and treatment process, unnecessary and unreasonable diagnosis and treatment behaviors are reduced, the hospitalization time is standardized, the medical resource consumption is rationalized, and the medical expense is controlled to be increased. However, although clinical path forms issued by the country and each hospital contain diagnosis and treatment items of applicable objects, diagnoses and diagnosis and treatment stages, specific medication, consumables and cost have no clear guidance scheme for selection of diagnosis and treatment schemes, and particularly, the diagnosis and treatment items and the specific medication and consumable guidance schemes are not available in scenes with larger resource consumption such as surgery, anesthesia and the like. The method also enables the traditional clinical path to not control the resource consumption and diagnosis and treatment behaviors under the operation and anesthesia, and for the diagnosis and treatment behaviors mentioned in the clinical path, the resource consumption under the diagnosis and treatment behaviors cannot be controlled, so that the consumption difference of each department and each doctor is large, and the accurate cost control cannot be achieved.
Disclosure of Invention
In order to overcome the defects in the prior art, the application provides a clinical path forming system, a clinical path forming method, corresponding equipment and a storage medium, which can automatically form or update a clinical path meeting the actual and development needs and realize standard treatment and accurate cost control.
In a first aspect of the application, there is provided a clinical pathway forming system, the system comprising:
a disease-specific clinical path determination module for determining whether there is a disease-specific clinical path, wherein the disease-specific clinical path is one of national version clinical paths;
a first disease-specific clinical path tag usage rate calculation module for calculating, in response to determining a disease-specific clinical path having the disease species, a usage rate of each disease-specific clinical path tag according to pre-constructed disease-specific clinical path tags, wherein the disease-specific clinical path tags represent clinical diagnosis and treatment items and are respectively matched with charge items or doctor orders data of the disease species of the corresponding hospital, wherein each charge item or doctor order can correspond to only one disease-specific clinical path tag;
the first special disease clinical path label recommending module is used for generating a first special disease recommending removing and/or incorporating and/or replacing label according to a first preset special disease criterion according to the calculated use rate of each special disease clinical path label;
and the first hospital clinical path generation module is used for modifying the hospital clinical path according to the first special disease recommendation removal and/or inclusion and/or substitution label and taking the modified special disease clinical path as the hospital clinical path.
In an embodiment, the system further comprises: an intra-hospital clinical path determination module for determining whether there is an intra-hospital clinical path for the disease species; an intra-hospital clinical path tag usage rate calculation module for calculating a usage rate of each intra-hospital clinical path tag according to pre-constructed intra-hospital clinical path tags in response to determining an intra-hospital clinical path having the disease, wherein the intra-hospital clinical path tags represent clinical diagnosis and treatment items and are respectively matched with charge items or orders data of the disease of a corresponding hospital, wherein each charge item or order can correspond to only one intra-hospital clinical path tag; the hospital clinical path label recommending module is used for generating hospital recommended removal and/or inclusion and/or replacement labels according to preset hospital criteria according to the calculated use rate of the clinical path labels of the specific diseases and the use rate of the clinical path labels of the specific diseases; and the intra-hospital clinical path updating module is used for updating the intra-hospital clinical path according to the intra-hospital recommended removal and/or inclusion and/or substitution labels.
In an embodiment, the system further comprises: a second disease-specific clinical path tag usage rate calculation module for calculating usage rates of each disease-specific clinical path tag according to pre-constructed disease-specific clinical path tags in response to determining that there is no disease-specific clinical path of the disease species; the second special disease clinical path label recommending module is used for generating a second special disease recommending inclusion label according to a second preset special disease criterion according to the calculated use rate of each special disease clinical path label; and the second hospital clinical path generation module is used for generating a hospital clinical path according to the second special disease recommendation inclusion label.
In an embodiment, the system further comprises an expert criticizing module for accepting a secondary confirmation of the recommended tag by the expert.
In an embodiment, the system further comprises a viewing module for viewing at least the calculated clinical path label usage results.
In a second aspect of the application, there is provided a method of clinical pathway formation, the method comprising:
determining whether there is a disease specific clinical pathway of a disease species, wherein the disease specific clinical pathway is one of national version clinical pathways;
in response to determining a disease-specific clinical path having the disease species, calculating a utilization rate of each disease-specific clinical path tag according to pre-constructed disease-specific clinical path tags, wherein the disease-specific clinical path tags represent clinical diagnosis and treatment items and are respectively matched with charge items or doctor orders data of the disease species of the corresponding hospital, wherein each charge item or doctor orders can only correspond to one disease-specific clinical path tag;
generating a first specific disease recommendation removal and/or inclusion and/or substitution label according to a first predetermined specific disease criterion according to the calculated use rate of each specific disease clinical path label;
modifying the dedicated disease clinical path according to the first dedicated disease recommendation removal and/or inclusion and/or replacement tags and taking the modified dedicated disease clinical path as an intra-hospital clinical path.
In a third aspect of the application there is provided a computer device comprising a processor, a memory and a computer program stored on the memory and executable on the processor, wherein the processor when executing the computer program performs the functions of the system according to the first aspect of the application or the steps of the method according to the second aspect of the application.
According to a fourth aspect of the present application there is provided a computer readable storage medium having stored thereon a computer program which when executed by a processor performs the functions of the system according to the first aspect of the present application or the steps of the method according to the second aspect of the present application.
The clinical path label constructed based on the disease type past data measurement and calculation is compared with the existing clinical path, and an optimization scheme conforming to the diagnosis and treatment characteristics of a hospital is generated, so that the effects of expanding the application range of the clinical path, standardizing the operation of doctors and improving the disease type diameter entering rate are achieved. Meanwhile, the clinical path can be thinned to a medication scheme, a consumable class, a management and control cost range and the like, so that the cost management and control effect of the clinical path is improved, and the purposes of ensuring medical quality and reducing medical cost are realized. In particular, the beneficial effects of the application relative to the existing solutions include:
1) Based on the past data, optimizing the clinical path, removing the diagnosis and treatment project which is not commonly used and bringing the diagnosis and treatment project into common use, so that the establishment of the clinical path is more scientific and accords with the actual condition of a hospital;
2) The medical diagnosis and treatment system can calculate and present the use conditions of doctors and departments of the diagnosis and treatment items in the existing clinical path, help hospitals to visually see the use preference of the doctors and departments for the diagnosis and treatment items at present, and find abnormal diagnosis and treatment behaviors in time;
3) And (3) commenting recommended result organization specialists which are different from the original paths, and referring to the specialist comments to obtain a final optimization scheme result so as to combine data measurement and calculation with clinical experience.
Other features and advantages of the present application will become more apparent from the following detailed description of embodiments of the present application, which is to be read in connection with the accompanying drawings.
Drawings
FIG. 1 is a block diagram of one embodiment of a system according to the present application;
fig. 2 is a flow chart of an embodiment of the method according to the application.
For the sake of clarity, these figures are schematic and simplified drawings, which only give details which are necessary for an understanding of the application, while other details are omitted.
Detailed Description
Embodiments and examples of the present application will be described in detail below with reference to the accompanying drawings.
The scope of applicability of the present application will become apparent from the detailed description given hereinafter. It should be understood, however, that the detailed description and specific examples, while indicating preferred embodiments of the application, are given by way of illustration only.
Fig. 1 shows a block diagram of a preferred embodiment of a clinical path forming system according to the present application. The system comprises:
the disease seed selection module 102 is used for selecting disease seeds needing to be optimized or generated into a clinical path according to own requirements by a patio or a researcher.
The disease-specific clinical path determination module 104 is configured to determine whether a disease-specific clinical path of the selected disease species exists, wherein the disease-specific clinical path refers to a national version clinical path issued by national defense commission.
The first disease-specific clinical path tag usage rate calculation module 106 is configured to calculate, when determining a disease-specific clinical path having a selected disease type, a usage rate of each disease-specific clinical path tag according to a pre-constructed disease-specific clinical path tag, wherein the disease-specific clinical path tag represents a clinical diagnosis and treatment item and is matched with a charge item or order data of the selected disease type of the corresponding hospital, respectively.
The disease-specific clinical pathway signature may be constructed as follows. For diagnosis and treatment projects related in the clinical path of the disease type (selected disease type) of the national edition, the project names in the clinical path of the disease type of the national edition are applied as the names of all the labels, and charging project/doctor's advice data related to the disease type are matched to all the labels. For the projects not related to the national version clinical path of the disease, the standardization classification is carried out according to the following standardization rules, the names are created by referring to the national clinical path expression mode, and the charging projects or orders are matched to the labels. One label may contain multiple charge items or multiple orders, but one label may contain only charge items or orders, not both, and one charge item/order may correspond to only one label.
Items not covered by the clinical path of the disease species of the national edition can construct tag names and match charged items/orders according to the following labeling rules. The clinical path labels of the specific diseases to be constructed are divided into three categories of consumable materials, medicines and medical service items. For medicines, for example, the charge items classified as medicines can be classified according to categories, and the label names are expressed as medicine categories (such as antacids, anti-emetics, etc.) with reference to the national clinical route expression mode, referring to, for example, the 2019 edition of the national medical insurance medicine catalogue. For consumable, for example, reference may be made to "medical instruments catalogue", and the charging items classified as consumable are classified according to the category, and a certain diagnosis and treatment item object (such as an oxygen absorbing object, an infusion object, etc.) related to the tag is preferentially adopted, if there is no consumable of the corresponding diagnosis and treatment item, the tag name is expressed as the consumable category (such as dressing, hemostatic material, etc.). For medical service projects, firstly, the medical orders except the description medical orders in the medical order list are standardized, and the expression modes of the medical orders are standardized to form standardized medical orders. All orders except the orders (or at least orders covering examination, electronic application, consultation) will then be described for classification, with the tag name expressed as a diagnostic item (e.g. abdominal ultrasound, nebulized inhalation, etc.) with reference to the national clinical pathway expression. Judging whether the 'standardized medical advice' covers all the charging items with the category of medical service items by using a medical advice and charging item mapping relation table, and for the charging items without the corresponding standardized medical advice, classifying the charging items according to the diagnosis and treatment items to form a label, wherein the label name is expressed as the diagnosis and treatment items (such as II-level nursing and the like) by referring to the national clinical path expression mode, for example, the 2012 version of the national medical service item is used as a reference.
The specific clinical path label usage can be calculated, for example, as follows:
specific clinical pathway label usage = 100% of the number of cases/total number of cases involved in the specific clinical pathway label. The number of medical records related to the label is calculated from a hospital charge item list or a doctor's advice list.
In an embodiment, the dedicated disease clinical path labeling physician usage and/or dedicated disease clinical path labeling department usage may also be calculated:
specific clinical path label a doctor's rate of use = 100% of the number of doctor's cases/total number of doctor's cases referred to by the specific clinical path label.
Specific clinical path label specific department use rate = 100% of the number of department cases/total number of department cases related to the specific clinical path label.
The first specific disease clinical path tag recommendation module 108 is configured to generate a first specific disease recommendation removal and/or inclusion and/or replacement tag according to a first predetermined specific disease criterion according to the calculated usage of each specific disease clinical path tag. That is, the application of the "dedicated disease clinical path tag" is compared with the national version clinical path, and recommendation inclusion/recommendation removal/recommendation alternatives are generated on the basis of the national clinical path. For example, a "dedicated clinical path label" that is the same as the item name in the national clinical path and has a usage rate of less than 30% is a recommended removal label; the "special disease clinical path label" which is different from the item name in the national clinical path but has the use rate of 50% or more is a recommended inclusion label; and for a specific disease clinical path label corresponding to the charging item of the operation and anesthesia, if the usage rate is more than or equal to 50%, recommending the specific disease clinical path label to optimize and replace the operation/anesthesia. Criteria for specific disease criteria such as usage thresholds may be set according to hospital practices.
The first hospital clinical path generating module 110 is configured to modify the clinical path of the specific disease according to the first specific disease recommendation, remove and/or incorporate and/or replace the label, and take the modified clinical path of the specific disease as the clinical path in the hospital, so that the clinical path is more consistent with the reality and science of the hospital.
In an embodiment, the clinical pathway forming system further comprises:
an intra-hospital clinical path determination module for determining whether an intra-hospital clinical path for the selected disease species is present. "hospital" refers to an application in a hospital;
and the intra-hospital clinical path label utilization rate calculation module is used for calculating the utilization rate of each intra-hospital clinical path label according to the pre-constructed intra-hospital clinical path label in response to determining the intra-hospital clinical path with the selected disease, wherein the intra-hospital clinical path label represents a clinical diagnosis and treatment project and is matched with the charge project or doctor's advice data of the disease of the corresponding hospital respectively. Specifically, the name of the item in the clinical path of the disease in the hospital can be used as the name of each label of the clinical path in the hospital, if the hospital has a corresponding relation table of the clinical path of the disease, the medical advice and the charging item mapping relation table is consulted, and the charging item/medical advice corresponding to the item in the clinical path of the hospital after the medical advice and the charging item in the mapping relation table are removed is the charging item/medical advice contained in the clinical path. If the hospital does not have a corresponding relation table of clinical paths, medical orders and charging items, the clinical path items are used as names, experience and clinical path item expression modes are combined to distinguish the clinical path items as medicines and other diagnosis and treatment items, for medicine diagnosis and treatment items, the national medical insurance catalogue can be used as a reference, the charging item names are classified and matched to the clinical path items, for other diagnosis and treatment items, for example, the national medical service item 2012 can be used as a reference, and the medical orders/charging items are matched to the clinical path items. The matching is similar to the healthcare item targeting rules in the targeting rules described above. Likewise, one label may contain multiple charge items or multiple orders, but one label may contain only charge items or orders, not both, and one charge item/order may correspond to only one label. The clinical path label usage rate in hospital is calculated as follows: clinical route label usage in a hospital = 100% of the number of medical records/total medical records referred to by the clinical route label in the hospital.
And the intra-hospital clinical path label recommending module is used for generating intra-hospital recommended removal and/or inclusion and/or replacement labels according to the preset intra-hospital criteria according to the calculated use rate of the clinical path labels of the specific diseases and the use rate of the clinical path labels of the specific diseases. For example, the "clinical path label in hospital" is recommended to be removed, the usage rate is less than 30%, and the corresponding "clinical path label in specific disease" is less than 50%; the utilization rate of the special disease clinical path label is greater than or equal to 50%, and the corresponding hospital clinical path label does not belong to the items in the hospital clinical path, and the special disease clinical path label is a recommended inclusion label. For a 'special disease clinical path label' of which the scene of a charging item belongs to surgery and anesthesia (an execution department/an opening department in a charging list is an operating room or an anesthesia department, or the charging item of which the application scene is surgery/anesthesia can be judged according to product use instructions, medical service item interpretation and the like), if the utilization rate is more than or equal to 50%, recommending the 'special disease clinical path label' to optimally replace surgery/anesthesia; for the use ratio of the clinical path label in hospital is less than 30%, but the use ratio of the clinical path label in specific disease is more than or equal to 50%, the clinical path label in specific disease is recommended to replace the clinical path label in hospital. Similarly, criteria such as usage thresholds for in-hospital criteria may be set based on hospital practices.
And the intra-hospital clinical path updating module is used for updating the intra-hospital clinical path according to the intra-hospital recommended removal and/or inclusion and/or replacement labels.
In an embodiment, the clinical pathway forming system further comprises:
a second disease-specific clinical path tag usage calculation module for calculating usage of each disease-specific clinical path tag from pre-constructed disease-specific clinical path tags in response to determining that there is no disease-specific clinical path of the selected disease species;
and the second special disease clinical path label recommending module is used for generating a second special disease recommendation inclusion label according to a second preset special disease criterion according to the calculated use rate of each special disease clinical path label. For example, the labels with the usage rate of 50% or more of the "special disease clinical path labels" are recommended inclusion labels;
and the second hospital clinical path generation module is used for generating a hospital clinical path according to the second special disease recommendation inclusion label.
In an embodiment, the clinical path forming system further comprises an expert criticizing module for accepting a secondary confirmation of the recommended label by the expert. And (3) the expert critizes the recommended inclusion/removal/replacement items based on clinical experience and the traditional clinical path, judges whether to include/remove/replace or not, and then generates or updates a clinical path based on the result after the expert critizes, wherein the clinical path comprises the optimized items in the clinical path, the associated names of the charging items and standard schemes (upper limit, lower limit and average value of the usage).
In an embodiment, the clinical path forming system further comprises a viewing module for viewing at least the calculated dedicated disease clinical path label usage, intra-hospital clinical path label usage, dedicated disease clinical path label doctor usage, and/or dedicated disease clinical path label department usage results.
In the embodiment, a recommended scheme of specific medication, consumable and usage under the diagnosis and treatment item in the clinical path can be provided, and particularly, the recommended scheme of specific medication item and specific medication, consumable and usage applied to special scenes with larger resource consumption such as surgery, anesthesia and the like replaces a mode of only controlling the surgery name in the traditional clinical path, so that accurate fee control is realized.
Fig. 2 shows a flow chart of a preferred embodiment of a clinical path forming method according to the present application.
In step S202, it is determined whether there is a disease-specific clinical pathway of a disease species, wherein the disease-specific clinical pathway is one of national version clinical pathways. If yes, the process proceeds to step S204; otherwise, the process proceeds to step S222.
In step S204, the usage rate of each disease-specific clinical path label is calculated according to pre-constructed disease-specific clinical path labels, wherein the disease-specific clinical path labels represent clinical diagnosis and treatment projects and are respectively matched with the charge projects or doctor orders data of the disease types of the corresponding hospitals, and each charge project or doctor orders can only correspond to one disease-specific clinical path label.
In step S206, a first specific disease recommendation removal and/or inclusion and/or replacement label is generated according to the calculated usage of each specific disease clinical path label according to a first predetermined specific disease criterion.
In step S208, the dedicated disease clinical path is modified according to the first dedicated disease recommendation removal and/or inclusion and/or replacement labels and the modified dedicated disease clinical path is taken as an intra-hospital clinical path.
In step S222, the use rate of each disease-specific clinical path tag is calculated from the pre-constructed disease-specific clinical path tags.
In step S224, a second specific disease recommendation inclusion tag is generated according to the calculated usage rate of each specific disease clinical path tag and a second predetermined specific disease criterion.
In step S226, an in-hospital clinical pathway is generated from the second specific disease recommendation inclusion tag.
In an embodiment, the clinical pathway forming method further comprises: determining whether there is an intra-hospital clinical pathway for the disease species; in response to determining an in-hospital clinical path having the disease, calculating a utilization rate of each in-hospital clinical path tag according to pre-constructed in-hospital clinical path tags, wherein the in-hospital clinical path tags represent clinical diagnosis and treatment items and are respectively matched with charge items or orders data of the disease of a corresponding hospital, wherein each charge item or order can correspond to only one in-hospital clinical path tag; generating a hospital recommended removal and/or inclusion and/or replacement label according to a preset hospital criterion according to the calculated use rate of each specific disease clinical path label and the use rate of each hospital clinical path label; the intra-hospital clinical path is updated according to the intra-hospital recommendation to remove and/or incorporate and/or replace tags.
In another embodiment, the present application provides a computer readable storage medium, on which a computer program is stored, which when executed by a processor, implements the functions of the system embodiment or other corresponding system embodiments shown and described in connection with fig. 1 or implements the steps of the method embodiment or other corresponding method embodiments shown and described in connection with fig. 2, which are not repeated herein.
In another embodiment, the present application provides a computer device, including a processor, a memory, and a computer program stored on the memory and capable of running on the processor, where the processor implements the functions of the system embodiment or other corresponding system embodiments shown and described in connection with fig. 1 or implements the steps of the method embodiment or other corresponding method embodiments shown and described in connection with fig. 2 when the processor executes the computer program, and will not be described herein.
The various embodiments described herein, or particular features, structures, or characteristics thereof, may be combined as suitable in one or more embodiments of the application. In addition, in some cases, the order of steps described in the flowcharts and/or flow-line processes may be modified as appropriate and need not be performed in exactly the order described. Additionally, various aspects of the application may be implemented using software, hardware, firmware, or a combination thereof and/or other computer-implemented modules or devices that perform the described functions. A software implementation of the present application may include executable code stored in a computer readable medium and executed by one or more processors. The computer-readable medium may include a computer hard drive, ROM, RAM, flash memory, a portable computer storage medium such as CD-ROM, DVD-ROM, flash drives and/or other devices having a Universal Serial Bus (USB) interface, and/or any other suitable tangible or non-transitory computer-readable medium or computer memory on which executable code may be stored and executed by a processor. The application may be used in connection with any suitable operating system.
As used herein, the singular forms "a", "an" and "the" include plural referents (i.e., having the meaning of "at least one") unless otherwise indicated. It will be further understood that the terms "has," "comprises," "including" and/or "comprising," when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. The term "and/or" as used herein includes any and all combinations of one or more of the associated listed items.
While the foregoing is directed to some preferred embodiments of the present application, it should be emphasized that the present application is not limited to these embodiments, but may be embodied in other forms within the scope of the inventive subject matter. Various changes and modifications may be made by one skilled in the art without departing from the spirit of the application, and these changes or modifications still fall within the scope of the application.
Claims (10)
1. A clinical pathway forming system, the system comprising:
a disease-specific clinical path determination module for determining whether there is a disease-specific clinical path, wherein the disease-specific clinical path is one of national version clinical paths;
a first disease-specific clinical path tag usage rate calculation module for calculating, in response to determining a disease-specific clinical path having the disease species, a usage rate of each disease-specific clinical path tag according to pre-constructed disease-specific clinical path tags, wherein the disease-specific clinical path tags represent clinical diagnosis and treatment items and are respectively matched with charge items or doctor orders data of the disease species of the corresponding hospital, wherein each charge item or doctor order can correspond to only one disease-specific clinical path tag;
the first special disease clinical path label recommending module is used for generating a first special disease recommending removing and/or incorporating and/or replacing label according to a first preset special disease criterion according to the calculated use rate of each special disease clinical path label;
and the first hospital clinical path generation module is used for modifying the hospital clinical path according to the first special disease recommendation removal and/or inclusion and/or substitution label and taking the modified special disease clinical path as the hospital clinical path.
2. The system of claim 1, wherein the system further comprises:
an intra-hospital clinical path determination module for determining whether there is an intra-hospital clinical path for the disease species;
an intra-hospital clinical path tag usage rate calculation module for calculating a usage rate of each intra-hospital clinical path tag according to pre-constructed intra-hospital clinical path tags in response to determining an intra-hospital clinical path having the disease, wherein the intra-hospital clinical path tags represent clinical diagnosis and treatment items and are respectively matched with charge items or orders data of the disease of a corresponding hospital, wherein each charge item or order can correspond to only one intra-hospital clinical path tag;
the hospital clinical path label recommending module is used for generating hospital recommended removal and/or inclusion and/or replacement labels according to preset hospital criteria according to the calculated use rate of the clinical path labels of the specific diseases and the use rate of the clinical path labels of the specific diseases;
and the intra-hospital clinical path updating module is used for updating the intra-hospital clinical path according to the intra-hospital recommended removal and/or inclusion and/or substitution labels.
3. The system of claim 1, wherein the system further comprises:
a second disease-specific clinical path tag usage rate calculation module for calculating usage rates of each disease-specific clinical path tag according to pre-constructed disease-specific clinical path tags in response to determining that there is no disease-specific clinical path of the disease species;
the second special disease clinical path label recommending module is used for generating a second special disease recommending inclusion label according to a second preset special disease criterion according to the calculated use rate of each special disease clinical path label;
and the second hospital clinical path generation module is used for generating a hospital clinical path according to the second special disease recommendation inclusion label.
4. A system according to any one of claims 1-3, wherein the system further comprises:
and the expert criticizing module is used for receiving the secondary confirmation of the expert on the recommended label.
5. A system according to any one of claims 1-3, wherein the system further comprises:
and the checking module is used for checking at least the calculated clinical path label use rate result.
6. A method of clinical pathway formation, the method comprising:
determining whether there is a disease specific clinical pathway of a disease species, wherein the disease specific clinical pathway is one of national version clinical pathways;
in response to determining a disease-specific clinical path having the disease species, calculating a utilization rate of each disease-specific clinical path tag according to pre-constructed disease-specific clinical path tags, wherein the disease-specific clinical path tags represent clinical diagnosis and treatment items and are respectively matched with charge items or doctor orders data of the disease species of the corresponding hospital, wherein each charge item or doctor orders can only correspond to one disease-specific clinical path tag;
generating a first specific disease recommendation removal and/or inclusion and/or substitution label according to a first predetermined specific disease criterion according to the calculated use rate of each specific disease clinical path label;
modifying the dedicated disease clinical path according to the first dedicated disease recommendation removal and/or inclusion and/or replacement tags and taking the modified dedicated disease clinical path as an intra-hospital clinical path.
7. The method of claim 6, wherein the method further comprises:
determining whether there is an intra-hospital clinical pathway for the disease species;
in response to determining an in-hospital clinical path having the disease, calculating a utilization rate of each in-hospital clinical path tag according to pre-constructed in-hospital clinical path tags, wherein the in-hospital clinical path tags represent clinical diagnosis and treatment items and are respectively matched with charge items or orders data of the disease of a corresponding hospital, wherein each charge item or order can correspond to only one in-hospital clinical path tag;
generating a hospital recommended removal and/or inclusion and/or replacement label according to a preset hospital criterion according to the calculated use rate of each specific disease clinical path label and the use rate of each hospital clinical path label;
the intra-hospital clinical path is updated according to the intra-hospital recommendation to remove and/or incorporate and/or replace tags.
8. The method according to claim 6 or 7, characterized in that the method further comprises:
in response to determining that there is no disease-specific clinical path for the disease species, calculating a utilization rate of each disease-specific clinical path tag according to pre-constructed disease-specific clinical path tags;
generating a second special disease recommendation inclusion label according to the calculated use rate of each special disease clinical path label and a second preset special disease criterion;
and generating an in-hospital clinical path according to the second special disease recommendation inclusion label.
9. A computer device comprising a processor, a memory and a computer program stored on the memory and executable on the processor, wherein the processor implements the functions of the system according to any one of claims 1-5 or the steps of the method according to any one of claims 6-8 when the computer program is executed.
10. A computer readable storage medium having stored thereon a computer program which, when executed by a processor, implements the functions of the system according to any of claims 1-5 or the steps of the method according to any of claims 6-8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110459519.6A CN113421639B (en) | 2021-04-27 | 2021-04-27 | Clinical path forming system, method, corresponding equipment and storage medium |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110459519.6A CN113421639B (en) | 2021-04-27 | 2021-04-27 | Clinical path forming system, method, corresponding equipment and storage medium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113421639A CN113421639A (en) | 2021-09-21 |
| CN113421639B true CN113421639B (en) | 2023-11-10 |
Family
ID=77711928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110459519.6A Active CN113421639B (en) | 2021-04-27 | 2021-04-27 | Clinical path forming system, method, corresponding equipment and storage medium |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113421639B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115346647A (en) * | 2022-07-26 | 2022-11-15 | 杭州吉音医疗科技有限公司 | Intelligent DIP clinical path planning management information method and system |
Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0013811D0 (en) * | 1999-06-09 | 2000-07-26 | Curapath Systems Inc | Method for performing activity based costing for health care provider facilities |
| CN101853432A (en) * | 2010-01-25 | 2010-10-06 | 田小平 | System and method for controlling medical performance |
| CN102567607A (en) * | 2010-12-28 | 2012-07-11 | 广州中医药大学第二附属医院 | Clinic path information system |
| CN103679602A (en) * | 2012-09-25 | 2014-03-26 | 大连运邦科技发展有限公司 | Clinical pathway medical management system |
| CN106021967A (en) * | 2016-07-12 | 2016-10-12 | 上海市浦东新区周浦医院 | Data processing method for clinical pathway quality evaluation |
| CN106228023A (en) * | 2016-08-01 | 2016-12-14 | 清华大学 | A kind of clinical path method for digging based on body and topic model |
| CN107038344A (en) * | 2017-04-24 | 2017-08-11 | 大连诺道认知医学技术有限公司 | A kind of disease actual clinical path and standard clinical route comparing method and device |
| CN107798621A (en) * | 2017-08-30 | 2018-03-13 | 平安科技（深圳）有限公司 | Medical diagnosis on disease signal auditing method and device |
| CN108538349A (en) * | 2018-03-28 | 2018-09-14 | 深圳市前海安测信息技术有限公司 | Hospital clinical path based on clinical path variance analysis adjusts system and method |
| CN109785916A (en) * | 2019-01-24 | 2019-05-21 | 柳州市工人医院 | A kind of clinical path system based on information for hospital platform |
| CN110119432A (en) * | 2019-03-29 | 2019-08-13 | 中国人民解放军总医院 | A kind of data processing method for medical platform |
| CN110957013A (en) * | 2018-09-27 | 2020-04-03 | 清华大学 | Method and device for localization of clinical pathways based on genetic algorithm |
| CN111192644A (en) * | 2019-12-11 | 2020-05-22 | 平安医疗健康管理股份有限公司 | Construction method and device of clinical path, computer equipment and storage medium |
| CN111816326A (en) * | 2020-07-22 | 2020-10-23 | 望海康信(北京)科技股份公司 | Hospital operation system |
| CN112185544A (en) * | 2020-09-10 | 2021-01-05 | 浙江传媒学院 | Semantic-based family medical consultation decision support method |
| CN112635030A (en) * | 2020-11-30 | 2021-04-09 | 望海康信(北京)科技股份公司 | Automatic generation system and method for fee control prompt, corresponding equipment and storage medium |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7890341B2 (en) * | 2002-12-09 | 2011-02-15 | Baxter International Inc. | System and a method for providing integrated access management for peritoneal dialysis and hemodialysis |
-
2021
- 2021-04-27 CN CN202110459519.6A patent/CN113421639B/en active Active
Patent Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0013811D0 (en) * | 1999-06-09 | 2000-07-26 | Curapath Systems Inc | Method for performing activity based costing for health care provider facilities |
| CN101853432A (en) * | 2010-01-25 | 2010-10-06 | 田小平 | System and method for controlling medical performance |
| CN102567607A (en) * | 2010-12-28 | 2012-07-11 | 广州中医药大学第二附属医院 | Clinic path information system |
| CN103679602A (en) * | 2012-09-25 | 2014-03-26 | 大连运邦科技发展有限公司 | Clinical pathway medical management system |
| CN106021967A (en) * | 2016-07-12 | 2016-10-12 | 上海市浦东新区周浦医院 | Data processing method for clinical pathway quality evaluation |
| CN106228023A (en) * | 2016-08-01 | 2016-12-14 | 清华大学 | A kind of clinical path method for digging based on body and topic model |
| CN107038344A (en) * | 2017-04-24 | 2017-08-11 | 大连诺道认知医学技术有限公司 | A kind of disease actual clinical path and standard clinical route comparing method and device |
| CN107798621A (en) * | 2017-08-30 | 2018-03-13 | 平安科技（深圳）有限公司 | Medical diagnosis on disease signal auditing method and device |
| CN108538349A (en) * | 2018-03-28 | 2018-09-14 | 深圳市前海安测信息技术有限公司 | Hospital clinical path based on clinical path variance analysis adjusts system and method |
| CN110957013A (en) * | 2018-09-27 | 2020-04-03 | 清华大学 | Method and device for localization of clinical pathways based on genetic algorithm |
| CN109785916A (en) * | 2019-01-24 | 2019-05-21 | 柳州市工人医院 | A kind of clinical path system based on information for hospital platform |
| CN110119432A (en) * | 2019-03-29 | 2019-08-13 | 中国人民解放军总医院 | A kind of data processing method for medical platform |
| CN111192644A (en) * | 2019-12-11 | 2020-05-22 | 平安医疗健康管理股份有限公司 | Construction method and device of clinical path, computer equipment and storage medium |
| CN111816326A (en) * | 2020-07-22 | 2020-10-23 | 望海康信(北京)科技股份公司 | Hospital operation system |
| CN112185544A (en) * | 2020-09-10 | 2021-01-05 | 浙江传媒学院 | Semantic-based family medical consultation decision support method |
| CN112635030A (en) * | 2020-11-30 | 2021-04-09 | 望海康信(北京)科技股份公司 | Automatic generation system and method for fee control prompt, corresponding equipment and storage medium |
Non-Patent Citations (2)
| Title |
|---|
| Reduced in-hospital mortality for heart failure with clinical pathways: the results of a cluster randomised controlled trial;Panella, M;QUALITY & SAFETY IN HEALTH CARE;第18卷(第5期);369-373 * |
| 关于临床路径的三个问题;阎惠中;;中国医院(第12期);32-34 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113421639A (en) | 2021-09-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Saab et al. | Capabilities of gemini models in medicine | |
| Spitzer et al. | The Pediatrix Babysteps® Data Warehouse and the Pediatrix QualitySteps improvement project system—tools for “meaningful use” in continuous quality improvement | |
| US8527293B2 (en) | Method and system for supporting clinical decision-making | |
| US20080235049A1 (en) | Method and System for Predictive Modeling of Patient Outcomes | |
| US8549030B2 (en) | Methods and apparatus to enhance queries in an affinity domain | |
| US20090094063A1 (en) | Display and method for medical procedure selection | |
| CN101107607A (en) | Procedural medicine workflow management | |
| US20080183497A1 (en) | Method and apparatus for internet-based community of health experts | |
| JP6731480B2 (en) | Long-term healthy patient profile for incidental findings | |
| US20150339447A1 (en) | Medical assistance device, operation method of medical assistance device, non-transitory computer-readable recording medium, and medical assistance system | |
| CN110046186B (en) | Health care network | |
| JP6992370B2 (en) | Computer equipment and methods for identifying medical resources utilized by patients given a potential diagnosis | |
| US11886686B2 (en) | User interface, system, and method for optimizing a patient problem list | |
| US20130159022A1 (en) | Clinical state timeline | |
| KR101295785B1 (en) | Apparatus and Method for Constructing Gene-Disease Relation Database | |
| CN113421639B (en) | Clinical path forming system, method, corresponding equipment and storage medium | |
| US20210174922A1 (en) | Medical care support apparatus | |
| US20200043583A1 (en) | System and method for workflow-sensitive structured finding object (sfo) recommendation for clinical care continuum | |
| US10867698B2 (en) | Systems and methods for improved health care cohort reporting | |
| US11610677B2 (en) | Patient health monitoring system | |
| Nan et al. | A Computer-Interpretable Guideline for COVID-19: Rapid Development and Dissemination | |
| Jiao et al. | The economic value and clinical impact of artificial intelligence in healthcare: a scoping literature review | |
| US20200027534A1 (en) | Device, system, and method for updating problem lists | |
| US20180189456A1 (en) | Indicator for probable inheritance of genetic disease | |
| CN114334104A (en) | Consumable consumption auditing method and system, corresponding equipment and storage medium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |